CNR Institutional Research Information System

CONTASTA, IDA ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.572
NA - Nord America 1.121
EU - Europa 321
SA - Sud America 305
AF - Africa 31
OC - Oceania 4
Totale 3.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.085
SG - Singapore 703
CN - Cina 323
BR - Brasile 253
HK - Hong Kong 196
VN - Vietnam 151
FR - Francia 102
IT - Italia 89
KR - Corea 46
IN - India 38
GB - Regno Unito 25
JP - Giappone 24
AR - Argentina 20
DE - Germania 20
BD - Bangladesh 17
CA - Canada 16
MX - Messico 15
ID - Indonesia 14
NL - Olanda 14
UA - Ucraina 11
EC - Ecuador 10
FI - Finlandia 10
IQ - Iraq 10
SE - Svezia 8
IL - Israele 7
SA - Arabia Saudita 7
VE - Venezuela 7
ZA - Sudafrica 7
AT - Austria 6
ES - Italia 6
JO - Giordania 6
KE - Kenya 6
MA - Marocco 6
PY - Paraguay 6
CO - Colombia 5
PK - Pakistan 5
PL - Polonia 5
TR - Turchia 5
AU - Australia 4
RS - Serbia 4
AL - Albania 3
EG - Egitto 3
IE - Irlanda 3
RU - Federazione Russa 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
KG - Kirghizistan 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
NP - Nepal 1
PE - Perù 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.354
Salva come PNG Salva come JPEG
Città #
Santa Clara 634
Singapore 415
Hong Kong 191
Hefei 116
San Jose 112
Beijing 78
Lauterbourg 77
Ho Chi Minh City 57
Ashburn 50
Hanoi 45
Seoul 44
Los Angeles 37
São Paulo 32
New York 18
Tokyo 17
Buffalo 15
Dallas 12
Helsinki 9
Orem 9
Frankfurt am Main 7
Mumbai 7
Quito 7
Rio de Janeiro 7
Dhaka 6
Minamishinagawa 6
Nairobi 6
Stockholm 6
Baghdad 5
Chennai 5
Chicago 5
Council Bluffs 5
Da Nang 5
Johannesburg 5
Phoenix 5
Riyadh 5
Rome 5
Thái Bình 5
Warsaw 5
Amman 4
Belo Horizonte 4
Biên Hòa 4
Bologna 4
Brasília 4
Düsseldorf 4
Kyiv 4
London 4
Manchester 4
Marigliano 4
Montreal 4
Ourinhos 4
Porto Alegre 4
Shanghai 4
Toronto 4
Asunción 3
Belgrade 3
Bengaluru 3
Boston 3
Brooklyn 3
Bình An 3
Campinas 3
Casablanca 3
Charlotte 3
Dublin 3
Guangzhou 3
Guayaquil 3
Ha Long 3
Houston 3
Jakarta 3
Kaohsiung 3
Mexico City 3
Milan 3
Montevideo 3
Nanjing 3
Newark 3
Osasco 3
Pescara 3
Piscataway 3
Pune 3
Quận Bình Thạnh 3
San Francisco 3
Serra 3
São Carlos 3
São Gonçalo 3
São José dos Campos 3
Tirana 3
Vienna 3
Volta Redonda 3
Addis Ababa 2
Ankara 2
Atlanta 2
Baku 2
Barueri 2
Bogotá 2
Buenos Aires 2
Cabo Frio 2
Caracas 2
Charleston 2
Chieti 2
Criciúma 2
Curitiba 2
Totale 2.263
Salva come PNG Salva come JPEG
Nome #
Classification of cancer stage using the immune system. 96
Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? 88
p53 and Ki-ras alterations in colorectal adenocarcinomas 72
Immunological mechanisms in the establishment and progression of colon cancer. 69
K-Ras mutations in colon adenocarcinomas 65
HLA class II genomic polymorphism in multiple sclerosis: evaluation of DQA-DPB alleles 57
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance. 57
Tipizzazione per sequenza degli antigeni HLA di classe I e II nel trapianto di rene. 57
CD30 Molecule, The Immune System and Multiple Sclerosis. 55
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy 53
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. 50
IL-8 involvement in immune disregulation of cancer patients 48
Polymorphism of DQA1 promoter in Italian population 46
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age 45
A gender-related action of IFNß-therapy was found in multiple sclerosis. 45
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy 45
Immunological pathways in diagnosis, treatment, cure and prevention of human disease: "Gender-Specific Cytokine Pathways, Targets and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer" 45
Medical research news in the understanding, diagnosis, treatment, cure or prevention of cancer disease: "ARE IMMUNOLOGICAL MECHANISMS INVOLVED IN COLON CANCER AND ARE THEY POSSIBLE MARKERS FOR BIOTHERAPY IMPROVEMENT?" 45
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy 44
Medical research news in the understanding, diagnosis, treatment, cure or prevention of human disease: "Ageing gender-specific targets/biomarkers for the identification of drugs with specific gender-related action and more appropriate therapeutic strategies." 44
Identification of a recombination event by DNA heteroduplex in a bone marrow transplant familial study 42
Immunological study of IFNbeta-1a treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy 42
CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance: The role of IFN beta-1a in the treatment of multiple sclerosis 41
Mutazioni di geni della famiglia ras nelle neoplasie del cavo orale e delle ghiandole annesse. 40
Novel Prognostic Biomarkers for Personalized Cancer Treatment 40
The immunological implications of gene alterations in the progression of colorectal cancer: indications for prognosis, treatment and tumor understanding. 40
Alleli HLA-DQ alfa nella sclerosi multipla 40
Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer 40
Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. 40
Prognostic indices for the early classification of colon cancer stage 39
Anti-HLA antibodies after soluble antigens absorption, genomic HLA compatibility and acute rejection in kidney transplantation 39
Differenze nel Locus HLA-DPB1 e risposta umorale nel trapianto di rene da donatore cadavere. 39
Anticorpi anti HLA e anti EM nei pazienti uremici in attesa di trapianto renale 39
Prognostic indices for the early classification of colon cancer stage. 38
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patients 38
Oncogeni e metastasi linfonodali in tumori primitivi del cavo orale 38
The study of patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. 38
Immunological mechanisms in the establishment and progression of colon caner 38
Analisi del linkage disequilibrium tra antigeni HLA di classe II in un campione della popolazione abruzzese. 38
Bcl-2 and drugs used in the treatment of cancer: New strategies of biotherapy which should not be underestimated. 37
Genotyping analysis of HLA Class II genes in Donor- Recipient Kidney Transplants Pairs 37
HLA DPB1 allaele is strongly associated to DR3 in coeliac disease 37
Incompatibilità HLA-DPB1 e CLM in coppie di trapianto di midollo tra correlati e non correlati. 37
Marcatori di linfociti nell'anziano in emodialisi periodica 36
HLA-DP?1 allele is strongly associated to DR3 in coeliac disease 36
MLC test and/or DNA typing in Bone Marrow transplantation 35
Immunological implications of alterations in the c-ki-ras and p53 gene in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding 35
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patienst 35
Immunological implications of alterations in the c-ki-ras and p53 gene in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding. 34
Ras family oncogenes in oral cancer 34
Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. 34
Analisi del DNA heteroduplex per il locus HLA-DP nel trapianto di midollo osseo. 33
Associazione degli alleli HLA DR-DQ mediante tipizzazione genomica nella popolazione del centro-sud d'Italia. 33
Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules 32
Genotyping analysis of HLA CLASS II genes in donor recipient kidney transplant pairs 32
p53 and K-ras genomic analysis in oral squamous cell carcinomas 32
Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer 32
Relationships between the activity of MMPI/TIMPI enzymes and the TH1/TH2 cytokine network 32
DQalfa2,4 and DPbeta1 role in coeliac disease 31
Antigeni HLA ed epatopatie croniche alcooliche 31
Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. 31
IFNbeta-1a treatment and reestablishment of TH1 regulation in MS patients: dose effects. 30
Simultaneous measurement of sCEA and TIMP1 serum levels for use as pre-invasive to invasive markers of colorectal cancer. 30
The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments 30
Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions 30
Identification of recombination event by DNA heteroduplex in a bone marrow transplant familiar study 29
Impact of DNA matching on acute rejection in renal transplantation 29
Primary involvement of HLA DQA1 0501- DQB1 0201 heterodimer in celiac disease 29
Comparison between HLA-DR serological typing and oligotyping in kidney transplant: a single centre experience 29
Primary involvment of HLA DQA1*0501-DQB1*0201 heterodimer in celiac disease 28
A comparative study of HLA-DRB1 by serological, PCR-SSO and PCR-SSP methods in donor-recipient kidney transplantation pairs 28
CD30: an important costimulator molecule in the regulation of the balance between TH1/TH2 response 28
Analisi del linkage disequilibrium tra HLA-DP/DR-DQ in un campione della popolazione Abruzzese. 28
Analisys of HLA-DP/DR-DQ linkage in a panel of unrelated bone marrow donors from a region of central Italy (Abruzzo). 27
Analysis of ras mutations by PCR in oral and digestive cancer. 27
Polimorfismo HLA- DQalfa nel trapianto di midollo osseo 26
Stadiazione genomica del cancro del colon e del retto. Biologia molecolare e citometria nel cancro del colon. 26
HLA Class II genomic polymorfism in multiple sclerosis: evaluation of DQA-DPB alleles 26
HLA-DPB1*0402 disparity with a negative MLC reactivity elicited GVHD in bone marrow recipient by a HLA-A-B-DR and DQ compatible sibling: a case report. 26
HLA genomic typing, MLC reactivity and GVHD onset in related and unrelated bone marrow transplantation 26
Elevata incidenza di alterazioni ras e p53 nei tumori del colon distale. 25
The Directory of On-going Cancer Research in the European Union 25
Ras mutations is a rare event in oral squamous-cell carcinomas. 25
The TH1 And TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments. 24
HLA-DRB1 sequence- specific amplification (SSP) compared to PCR-SSO and serological methods in kidney transplantation 24
K-Ras mutations are a frequent event in distal colon carcinomas 24
HLA-DPB1 impact on MLC reactivity in bone marrow transplantation 24
K-ras mutations in different sites of colorectal cancer. 23
Componente gruppo-specifico nella Sclerosi Multipla. 22
Totale 3.369
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.138
article - articoli 6.085
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.176
Totale 17.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202422 0 0 0 0 0 0 0 0 3 0 18 1
2024/20251.535 5 20 85 59 534 97 18 40 29 70 290 288
2025/20261.812 75 163 184 274 305 141 262 88 116 139 65 0
Totale 3.369